Home
PsOPsA Hub
PsOPsA Hub
Agenda
16:00 (GMT)
Paolo Gisondi

Welcome and introductions

16:05 (GMT)
Paolo Gisondi

Unmet needs for people of color with psoriatic disease and new guidance for diversity within clinical trials

16:20 (GMT)

All, led by Paolo Gisondi

Discussion and Q&A

16:25 (GMT)
Andrew AlexisMona Shahriari

Spotlight on the VISIBLE trial in people of color (NCT05272150)

16:45 (GMT)

All, led by Paolo Gisondi

Discussion and Q&A

16:55 (GMT)
Paolo Gisondi

Closing remarks and evaluation

Learning objectives

Upon completion of this activity, participants should be able to:

  • Appraise factors that can affect diagnosis of psoriasis in people of color
  • Recall key data from clinical trials for approved and pipeline treatments for psoriasis
  • Explain the considerations for optimal, individualized treatment selection
  • Describe best practice recommendations for the management of psoriasis in different populations, including people of color

Registration form

Registration is free. Please complete the form and submit to register.


The PsOPsA Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy